Ride-hailing company and Uber competitor Lyft will go public with 30.8 million shares at between $62 to $68 a pop.
Dow Futures Plunge after Wednesday’s Record Stock Market Rally
The US stock market doesn’t look poised to extend Wednesday’s record-setting after-Christmas rally, with S&P 500, Nasdaq 100, and Dow Jones Industrial Average futures all portending sharp declines ahead of
Oxford Biomedica PLC (AIM:OXB) enter into an $842.5 Million Exclusive Worldwide Licence Agreement
OXB and Axovant Sciences Licence Agreement
Nasdaq CEO: We’ll ‘Certainly Consider’ Becoming a Cryptocurrency Exchange
Nasdaq, the world’s second-largest stock exchange with a $9 trillion market cap, is open to becoming a cryptocurrency exchange in a regulated market. In a televised interview with CNBC’s Squawk
How Sequoia’s $2 billion Dropbox win became as big as it is
Dropbox CEO Drew Houston Steve Jennings/Getty Images for TechCrunch By Theodore Schleifer @teddyschleifer Dropbox doesn’t have a typical venture capital history. Image: trapptechnology.com When founder Drew Houston rang the opening bell
Nasdaq-Listed Marathon Begins Bitcoin Mining Operations, Stock Up 32%
Images courtesy of Shutterstock. Traditional stock investors have just gotten another avenue for indirect exposure to the bitcoin market. A Nasdaq exchange listed former patent management company, Marathon, has
Interactive Brokers LLC (NASDAQ:IBKR) Starts 2018 with a Milestones, Half a Million Clients in January
Photo: Bloomberg Last month, Interactive Brokers said that the sweeping changes to US tax law knocked about $84 million off its profits. Interactive Brokers LLC (NASDAQ:IBKR) has just disclosed
Avacta Group plc (AIM:AVCT) Avacta and OncoSec to Collaborate
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, and OncoSec Medical Incorporated (“OncoSec”) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, are pleased to announce they
Motif Bio Plc (AIM,NASDAQ:MTFB) Filing of U.S. Shelf Registration
Motif Bio® plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company has filed a “universal” shelf registration statement on Form F-3 with
CEO Maxim Barskiy speaks to us about NASDAQ-listed Matra Petroleum AB
Matra Petroleum AB (NASDAQ:MATRA) is a Swedish independent oil and gas exploration and production company operating in the United States. With proven reserves of 22.9 million barrels of oil equivalent
Motif Bio Plc (AIM,NASDAQ:MTFB) Iclaprim granted Orphan Drug Designation by US FDA
Motif Bio plc (AIM/NASDAQ: MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the US Food and Drug Administration (“FDA”) has granted its investigational drug
